NHS PREDICT Breast Cancer Prognostic Model
PREDICT is the NHS-developed prognostic model that estimates overall and breast cancer-specific survival at 5 and 10 years, with and without adjuvant therapy, for early invasive breast cancer.
- Purpose:
- Estimate survival benefit of adjuvant chemotherapy, endocrine therapy, and trastuzumab
- Population:
- Women with early invasive breast cancer (operable, non-metastatic)
- Factors:
- Age, Tumour size, Tumour grade, Positive nodes, ER status, HER2 status, KI-67, Detection method
- Reference:
- Wishart et al., Breast Cancer Research 2010; PREDICT v2.2
HomePREDICT Breast (Prognostic Index)